ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-17.27%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$58.4M
AUM Growth
+$58.4M
Cap. Flow
-$10.1M
Cap. Flow %
-17.23%
Top 10 Hldgs %
93.6%
Holding
16
New
1
Increased
6
Reduced
5
Closed
1

Top Buys

1
PTGX icon
Protagonist Therapeutics
PTGX
$2.96M
2
DTIL icon
Precision BioSciences
DTIL
$589K
3
BCYC
Bicycle Therapeutics
BCYC
$560K
4
BPMC
Blueprint Medicines
BPMC
$436K
5
RPTX icon
Repare Therapeutics
RPTX
$399K

Top Sells

1
MRUS icon
Merus
MRUS
$5.89M
2
RGNX icon
Regenxbio
RGNX
$4.52M
3
ARWR icon
Arrowhead Research
ARWR
$1.66M
4
STRO icon
Sutro Biopharma
STRO
$1.4M
5
ARVN icon
Arvinas
ARVN
$1.15M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$13.3M 20.06%
707,589
-88,224
-11% -$1.66M
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$11.3M 17.04%
129,600
+5,000
+4% +$436K
KYMR icon
3
Kymera Therapeutics
KYMR
$2.95B
$7.38M 11.13%
183,521
-25,222
-12% -$1.01M
ARVN icon
4
Arvinas
ARVN
$568M
$6.3M 9.5%
328,766
-60,000
-15% -$1.15M
BCYC
5
Bicycle Therapeutics
BCYC
$511M
$3.11M 4.68%
221,911
+40,000
+22% +$560K
PTGX icon
6
Protagonist Therapeutics
PTGX
$3.67B
$2.96M 4.46%
+76,592
New +$2.96M
RGNX icon
7
Regenxbio
RGNX
$451M
$2.68M 4.04%
346,302
-584,406
-63% -$4.52M
IMTX icon
8
Immatics
IMTX
$619M
$2.66M 4.01%
373,902
+40,400
+12% +$287K
SLN
9
Silence Therapeutics
SLN
$227M
$2.53M 3.81%
367,214
+50,000
+16% +$344K
ACET icon
10
Adicet Bio
ACET
$59.9M
$2.44M 3.67%
2,531,194
– –
DTIL icon
11
Precision BioSciences
DTIL
$57.8M
$2.04M 3.08%
536,376
+154,573
+40% +$589K
RPTX icon
12
Repare Therapeutics
RPTX
$71.7M
$1.69M 2.56%
1,293,715
+304,351
+31% +$399K
STRO icon
13
Sutro Biopharma
STRO
$72.7M
$916 ﹤0.01%
498
-762,000
-100% -$1.4M
AMGN icon
14
Amgen
AMGN
$155B
– –
0
– –
MRUS icon
15
Merus
MRUS
$4.98B
– –
-117,855
Closed -$5.89M
SPY icon
16
SPDR S&P 500 ETF Trust
SPY
$658B
– –
0
– –